Literature DB >> 19073729

Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivo.

M Puntel1, R J Barrett, S Mondkar, V Saxena, K M Kroeger, A K M Muhammad, C Liu, N Bondale, S Sciascia, W Xiong, Y Shi, A Salem, A Zadmehr, P Huynh, D Palmer, P Ng, M G Castro, P R Lowenstein.   

Abstract

Increased transgene expression per vector genome is an important goal in the optimization of viral vectors for gene therapy. Herein we demonstrate that herpes simplex virus type 1 (HSV1) thymidine kinase (TK) gene sequences (1,131 bp) fused to the 3' end of lacZ increase transgene expression from high-capacity adenoviral vectors (HCAd), but not from first-generation (Ad) vectors. The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE), in contrast, increased transgene expression levels from Ad but not HCAd vectors. The differential activity of the HSV1 TK gene and WPRE sequences was detected both in vitro and in vivo and suggests potentially different mechanisms of action or the interaction of these elements with vector genomic sequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073729      PMCID: PMC2643782          DOI: 10.1128/JVI.01298-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Preparation of helper-dependent adenoviral vectors.

Authors:  Philip Ng; Robin J Parks; Frank L Graham
Journal:  Methods Mol Med       Date:  2002

2.  Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

Authors:  M A Schnell; Y Zhang; J Tazelaar; G P Gao; Q C Yu; R Qian; S J Chen; A N Varnavski; C LeClair; S E Raper; J M Wilson
Journal:  Mol Ther       Date:  2001-05       Impact factor: 11.454

3.  Preexisting antiadenoviral immunity is not a barrier to efficient and stable transduction of the brain, mediated by novel high-capacity adenovirus vectors.

Authors:  C E Thomas; G Schiedner; S Kochanek; M G Castro; P R Lowenstein
Journal:  Hum Gene Ther       Date:  2001-05-01       Impact factor: 5.695

4.  Switching on and off transgene expression within lactotrophic cells in the anterior pituitary gland in vivo.

Authors:  J R Smith-Arica; J C Williams; D Stone; J Smith; P R Lowenstein; M G Castro
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

5.  Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.

Authors:  R Ketteler; S Glaser; O Sandra; U M Martens; U Klingmüller
Journal:  Gene Ther       Date:  2002-04       Impact factor: 5.250

6.  Towards global and long-term neurological gene therapy: unexpected transgene dependent, high-level, and widespread distribution of HSV-1 thymidine kinase throughout the CNS.

Authors:  A J Zermansky; F Bolognani; D Stone; C M Cowsill; G Morrissey; M G Castro; P R Löwenstein
Journal:  Mol Ther       Date:  2001-11       Impact factor: 11.454

7.  PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver.

Authors:  Maria A Croyle; Narendra Chirmule; Yi Zhang; James M Wilson
Journal:  Hum Gene Ther       Date:  2002-10-10       Impact factor: 5.695

8.  Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.

Authors:  Mario R Mautino; Richard A Morgan
Journal:  Hum Gene Ther       Date:  2002-06-10       Impact factor: 5.695

9.  High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors.

Authors:  F Moreau-Gaudry; P Xia; G Jiang; N P Perelman; G Bauer; J Ellis; K H Surinya; F Mavilio; C K Shen; P Malik
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

10.  Adenoviral-mediated, high-level, cell-specific transgene expression: a SYN1-WPRE cassette mediates increased transgene expression with no loss of neuron specificity.

Authors:  Colin P J Glover; Alison S Bienemann; Darren J Heywood; A Siobhan Cosgrave; James B Uney
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

View more
  2 in total

1.  Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines.

Authors:  Aziz Alami Chentoufi; Lbachir BenMohamed
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

2.  Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.

Authors:  Gabriella Cotugno; Patrizia Annunziata; Maria Vittoria Barone; Marianthi Karali; Sandro Banfi; Alberto Auricchio
Journal:  PLoS One       Date:  2012-03-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.